{
    "code": "01055966",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01055966",
    "time": "2019-06-28 03:34:55",
    "許可證字號": "衛署藥製字第055966號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "110\/03\/18",
    "發證日期": "100\/03\/18",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00105596606",
    "中文品名": "達比黴素凍晶注射劑",
    "英文品名": "Tapi mycin Lyo-Injection",
    "適應症": "對Piperacillin具有感受性，以及對Piperacillin具有抗藥性但對Piperacillin\/Tarzobatam有感受性之β-lactamase產生菌株所引起之中至嚴重程度感染。",
    "劑型": "243凍晶注射劑",
    "包裝": "2.25公克、4.5公克小瓶裝 100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "主成分略述": "PIPERACILLIN (SODIUM), TAZOBACTAM (AS SODIUM)",
    "主製造廠": {
        "申請商名稱": "0502110200  永信藥品工業股份有限公司",
        "申請商地址": "台中市大甲區頂店里中山路一段1191號",
        "主製造廠": "",
        "製造廠名稱": "0520910300  永信藥品工業股份有限公司台中幼獅三廠"
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0812691910",
            "成分名稱": "PIPERACILLIN (SODIUM)",
            "含量描述": "(Potency)",
            "含量": "2.0000000000",
            "單位": "GM"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "4410000710",
            "成分名稱": "TAZOBACTAM (AS SODIUM)",
            "含量描述": "(Potency)",
            "含量": "0.2500000000",
            "單位": "GM"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "0812691910",
            "成分名稱": "PIPERACILLIN (SODIUM)",
            "含量描述": "(Potency)",
            "含量": "4.0000000000",
            "單位": "GM"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "4410000710",
            "成分名稱": "TAZOBACTAM (AS SODIUM)",
            "含量描述": "(Potency)",
            "含量": "0.5000000000",
            "單位": "GM"
        }
    ],
    "仿單外盒": [
        {
            "title": "010559660001-108-03-27.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01055966&Seq=002&Type=9"
        },
        {
            "title": "010559660001-107-05-21(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01055966&Seq=001&Type=9"
        },
        {
            "title": "達比黴素凍晶注射劑01055966_4.5標籤-106-08-02.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01055966&Seq=005&Type=8"
        },
        {
            "title": "達比黴素凍晶注射劑01055966_2.25標籤-106-08-02.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01055966&Seq=004&Type=8"
        },
        {
            "title": "達比黴素凍晶注射劑01055966_4.5外盒-106-08-02.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01055966&Seq=003&Type=8"
        },
        {
            "title": "達比黴素凍晶注射劑01055966_2.25外盒-106-08-02.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01055966&Seq=002&Type=8"
        },
        {
            "title": "01055966-標籤外盒___20110330.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01055966&Seq=001&Type=8"
        }
    ]
}